MacroGenics To Receive $24.5 Million Milestone From Sanofi For TZIELD Approval
MacroGenics announced that it will receive a $24.5 million regulatory milestone payment from Sanofi following the FDA’s accelerated…
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…